Immunic Inc (IMUX)

NASDAQ HEALTHCARE
$14.20 +0.00% RSI 58 Neutral Add Alert

Moving Averages

SMA 200
$9.11
Price above

Company Profile

Immunic, Inc., a clinical-stage biopharmaceutical company, develops a line of selective oral immunology therapies for the treatment of chronic autoimmune and inflammatory diseases. The company is headquartered in New York, New York.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$188.79M
P/E Ratio
None
EPS
$-4.77
Beta
1.386
Dividend Yield
0.00%
52-Week High
$15.77
52-Week Low
$5.06

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 48.0
VRTX
Vertex Pharmaceuticals Inc
RSI 64.0
CRSP
CRISPR Therapeutics AG
RSI 56.0
RXRX
Recursion Pharmaceuticals Inc - Class A
RSI 49.0
MRNA
Moderna Inc
RSI 64.0
VKTX
Viking Therapeutics Inc
RSI 60.0
SRPT
Sarepta Therapeutics Inc
RSI 54.0
EDIT
Editas Medicine Inc
RSI 48.0
IOVA
Iovance Biotherapeutics Inc
RSI 54.0
NVAX
Novavax Inc
RSI 48.0

Data last updated: June 13, 2026 at 8:30 AM EDT

Track IMUX for free

Get e-mail RSI alerts when Immunic Inc enters oversold or overbought territory. Free forever.

Add Alert